China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China · Delayed Price · Currency is CNY 16.07
-0.03 (-0.19%)
Nov 6, 2026, 3:00 PM CST
SHA:600062 Market Cap
SHA:600062 has a market cap or net worth of 16.6 billion as of November 6, 2026. It is the 5,691st most valuable company in the world and the 969th biggest in China. Its market cap has decreased by 16.46% in one year.
Market Cap
16.60B
Enterprise Value
17.27B
Revenue
10.66B
Global Rank
Country Rank
#969 China
PE Ratio
10.69
ChartMarket Cap Chart
Since March 1, 2004, SHA:600062's market cap has increased from 9.40B to 16.60B, an increase of 76.50%. That is a compound annual growth rate of 2.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 16.60B | -12.12% |
| Dec 31, 2025 | 18.89B | -7.08% |
| Dec 31, 2024 | 20.32B | 5.43% |
| Dec 29, 2023 | 19.28B | 5.47% |
| Dec 30, 2022 | 18.28B | 31.03% |
| Dec 31, 2021 | 13.95B | 11.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Joincare Pharmaceutical Group Industry | 19.19B |
| Kangmei Pharmaceutical | 18.95B |
| Walvax Biotechnology | 18.70B |
| Zhejiang Hisun Pharmaceutical | 16.02B |
| Tonghua Dongbao Pharmaceutical | 15.71B |
| Shandong Buchang Pharmaceuticals | 15.69B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 14.61B |
| Harbin Pharmaceutical Group | 14.61B |